Category - New Drug Applications
Sunovion Resubmits New Drug Application for Apomorphine Sublingual Film
Supernus Submits New Drug Application for SPN-812 for the Treatment of ADHD
MC2 Therapeutics Announces FDA Acceptance of its New Drug Application for Wynzora™ Cream for Treatment of Plaque Psoriasis
Vertical Pharmaceuticals, LLC, an Osmotica Company, Announces Acceptance of New Drug Application by FDA for RVL-1201 (Oxymetazoline Hydrochloride Ophthalmic Solution, 0.1%) for Acquired Blepharoptosis (Droopy Eyelid)
Evofem Biosciences Resubmits New Drug Application to U.S. FDA for Amphora® for the Prevention of Pregnancy
Cassiopea Announces FDA Acceptance of its New Drug Application for Clascoterone Cream 1%
Alkermes Submits New Drug Application to U.S. Food and Drug Administration for ALKS 3831 for Treatment of Schizophrenia and Bipolar I Disorder
Agile Therapeutics Announces FDA Extension of Twirla NDA Review Period